Ind-Swift Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2026 ,inter alia, to consider and approve unaudited financial ....
INDSWFTLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ind-Swift Laboratories has informed BSE that its Board of Directors will meet on Saturday, January 31, 2026 to consider, approve and take on record the standalone and consolidated unaudited financial results for the quarter and nine months ended December 31, 2025. The notice was filed under Regulation 29 of SEBI LODR. The trading window closure for dealing in company securities has already been communicated to the stock exchanges via a letter dated December 30, 2025. No actual financial numbers have been disclosed in this filing.
This is a routine regulatory filing ahead of the Q3FY26 earnings announcement. Investors should await the actual results on or after January 31, 2026 to gauge the company's quarterly performance. Stock may remain in a quiet period until the results are announced.